adus20250930_10q.htm

0001468328

Addus HomeCare Corp

false

--12-31

Q3

2025

0.001

0.001

40,000

40,000

18,483

18,483

18,148

18,148

3

3

3.1

0.4

1

20

3

15

0

0

3.75

4.25

11.3

http://fasb.org/srt/2025#ChiefExecutiveOfficerMember

3

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

false

false

true

true

true

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

Included $2.3 million and $6.1 million related to the New York Asset Sale deferred payments as of September 30, 2025 and December 31, 2024, respectively.

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

0001468328
2025-01-01
2025-09-30

xbrli:shares

0001468328
2025-10-28

thunderdome:item

iso4217:USD

0001468328
2025-09-30

0001468328
2024-12-31

iso4217:USD
xbrli:shares

0001468328
2025-07-01
2025-09-30

0001468328
2024-07-01
2024-09-30

0001468328
2024-01-01
2024-09-30

0001468328
us-gaap:CommonStockMember
2025-06-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2025-06-30

0001468328
us-gaap:RetainedEarningsMember
2025-06-30

0001468328
2025-06-30

0001468328
us-gaap:CommonStockMember
2025-07-01
2025-09-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2025-07-01
2025-09-30

0001468328
us-gaap:RetainedEarningsMember
2025-07-01
2025-09-30

0001468328
us-gaap:CommonStockMember
2025-09-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2025-09-30

0001468328
us-gaap:RetainedEarningsMember
2025-09-30

0001468328
us-gaap:CommonStockMember
2024-12-31

0001468328
us-gaap:AdditionalPaidInCapitalMember
2024-12-31

0001468328
us-gaap:RetainedEarningsMember
2024-12-31

0001468328
us-gaap:CommonStockMember
2025-01-01
2025-09-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-09-30

0001468328
us-gaap:RetainedEarningsMember
2025-01-01
2025-09-30

0001468328
us-gaap:CommonStockMember
2024-06-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2024-06-30

0001468328
us-gaap:RetainedEarningsMember
2024-06-30

0001468328
2024-06-30

0001468328
us-gaap:CommonStockMember
2024-07-01
2024-09-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-30

0001468328
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-30

0001468328
us-gaap:CommonStockMember
2024-09-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2024-09-30

0001468328
us-gaap:RetainedEarningsMember
2024-09-30

0001468328
2024-09-30

0001468328
us-gaap:CommonStockMember
2023-12-31

0001468328
us-gaap:AdditionalPaidInCapitalMember
2023-12-31

0001468328
us-gaap:RetainedEarningsMember
2023-12-31

0001468328
2023-12-31

0001468328
us-gaap:CommonStockMember
2024-01-01
2024-09-30

0001468328
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-09-30

0001468328
us-gaap:RetainedEarningsMember
2024-01-01
2024-09-30

xbrli:pure

0001468328
us-gaap:EmployeeStockOptionMember
2025-07-01
2025-09-30

0001468328
us-gaap:EmployeeStockOptionMember
2024-07-01
2024-09-30

0001468328
us-gaap:EmployeeStockOptionMember
2025-01-01
2025-09-30

0001468328
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-09-30

0001468328
us-gaap:RestrictedStockMember
2025-07-01
2025-09-30

0001468328
us-gaap:RestrictedStockMember
2024-07-01
2024-09-30

0001468328
us-gaap:RestrictedStockMember
2025-01-01
2025-09-30

0001468328
us-gaap:RestrictedStockMember
2024-01-01
2024-09-30

0001468328
adus:NewYorkAssetSaleMember
2024-05-20

0001468328
adus:NewYorkAssetSaleMember
2024-05-20
2024-05-20

0001468328
adus:NewYorkAssetSaleMember
2024-10-01
2024-10-31

0001468328
adus:NewYorkAssetSaleMember
2024-01-01
2024-12-31

0001468328
adus:DeferredPaymentsMember
adus:NewYorkAssetSaleMember
2025-01-01
2025-09-30

0001468328
adus:NewYorkAssetSaleMember
2025-09-30

0001468328
adus:NewYorkPersonalCareOperationsMember
2025-09-30

utr:Y

0001468328
adus:HelpingHandsHomeCareServiceIncMember
2025-08-01
2025-08-01

0001468328
adus:HelpingHandsHomeCareServiceIncMember
2025-07-01
2025-09-30

0001468328
adus:HelpingHandsHomeCareServiceIncMember
2025-01-01
2025-09-30

0001468328
adus:HelpingHandsHomeCareServiceIncMember
2025-08-01

0001468328
adus:HelpingHandsHomeCareServiceIncMember
adus:StateLicensesMember
2025-08-01
2025-08-01

0001468328
adus:HospiceSegmentMember
2024-12-31

0001468328
adus:PersonalCareSegmentMember
2024-12-31

0001468328
adus:HomeHealthSegmentMember
2024-12-31

0001468328
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
adus:HospiceSegmentMember
2025-09-30

0001468328
adus:PersonalCareSegmentMember
2025-09-30

0001468328
adus:HomeHealthSegmentMember
2025-09-30

0001468328
adus:JacksonvilleAffiliateMember
2025-01-01
2025-01-01

0001468328
adus:JacksonvilleAffiliateMember
adus:PersonalCareSegmentMember
2025-01-01

0001468328
adus:GreatLakesHomeCareUnlimitedLLCMember
2025-03-01
2025-03-01

0001468328
adus:GreatLakesHomeCareUnlimitedLLCMember
adus:PersonalCareSegmentMember
2025-03-31

0001468328
adus:HelpingHandsHomeCareServiceIncMember
adus:PersonalCareSegmentMember
2025-09-30

0001468328
adus:GentivaAcquisitionMember
2025-01-01
2025-09-30

0001468328
srt:MinimumMember
2025-09-30

0001468328
srt:MaximumMember
2025-09-30

0001468328
us-gaap:CustomerRelationshipsMember
srt:MinimumMember
2025-09-30

0001468328
us-gaap:CustomerRelationshipsMember
srt:MaximumMember
2025-09-30

0001468328
us-gaap:CustomerRelationshipsMember
2025-09-30

0001468328
us-gaap:CustomerRelationshipsMember
2024-12-31

0001468328
us-gaap:TrademarksAndTradeNamesMember
srt:MinimumMember
2025-09-30

0001468328
us-gaap:TrademarksAndTradeNamesMember
srt:MaximumMember
2025-09-30

0001468328
us-gaap:TrademarksAndTradeNamesMember
2025-09-30

0001468328
us-gaap:TrademarksAndTradeNamesMember
2024-12-31

0001468328
us-gaap:NoncompeteAgreementsMember
srt:MinimumMember
2025-09-30

0001468328
us-gaap:NoncompeteAgreementsMember
srt:MaximumMember
2025-09-30

0001468328
us-gaap:NoncompeteAgreementsMember
2025-09-30

0001468328
us-gaap:NoncompeteAgreementsMember
2024-12-31

0001468328
us-gaap:LicensingAgreementsMember
srt:MinimumMember
2025-09-30

0001468328
us-gaap:LicensingAgreementsMember
srt:MaximumMember
2025-09-30

0001468328
us-gaap:LicensingAgreementsMember
2025-09-30

0001468328
us-gaap:LicensingAgreementsMember
2024-12-31

0001468328
adus:StateLicensingAgreementsMember
2025-09-30

0001468328
adus:StateLicensingAgreementsMember
2024-12-31

0001468328
adus:HelpingHandsHomeCareServiceIncMember
adus:StateLicensesMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
adus:NewYorkAssetSaleMember
2025-09-30

0001468328
adus:NewYorkAssetSaleMember
2024-12-31

0001468328
adus:ARPASpendingPlansMember
2025-07-01
2025-09-30

0001468328
adus:ARPASpendingPlansMember
2025-01-01
2025-09-30

0001468328
adus:ARPASpendingPlansMember
2025-09-30

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
2025-09-30

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
2024-12-31

0001468328
adus:CreditAgreementMember
2024-10-22

0001468328
adus:CreditAgreementMember
2024-10-22
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
srt:MinimumMember
us-gaap:PrimeRateMember
2024-10-22
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
srt:MaximumMember
us-gaap:PrimeRateMember
2024-10-22
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
adus:FederalFundsRateMember
2024-10-22
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
srt:MinimumMember
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
srt:WeightedAverageMember
us-gaap:SecuredOvernightFinancingRateSofrMember
2024-10-22

0001468328
adus:CreditAgreementMember
srt:MinimumMember
us-gaap:SecuredOvernightFinancingRateSofrMember
2024-10-22
2024-10-22

0001468328
adus:CreditAgreementMember
srt:MaximumMember
us-gaap:SecuredOvernightFinancingRateSofrMember
2024-10-22
2024-10-22

0001468328
adus:CreditAgreementMember
srt:MinimumMember
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
srt:MaximumMember
2024-10-22

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
2025-06-30

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CapitalOneNationalAssociationMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevolvingCreditFacilityMember
adus:CreditAgreementMember
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:PersonalCareMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HospiceMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HomeHealthMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:PersonalCareMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HospiceMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HomeHealthMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:PersonalCareMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HospiceMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HomeHealthMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
2025-07-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:PersonalCareMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HospiceMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HomeHealthMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:PersonalCareMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HospiceMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HomeHealthMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:PersonalCareMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HospiceMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HomeHealthMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
2024-07-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:PersonalCareMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HospiceMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HomeHealthMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:PersonalCareMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HospiceMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HomeHealthMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:PersonalCareMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HospiceMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HomeHealthMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
2025-01-01
2025-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:PersonalCareMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HospiceMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
adus:HomeHealthMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:PersonalCareMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HospiceMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
adus:HomeHealthMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:CostOfSalesMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:PersonalCareMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HospiceMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
adus:HomeHealthMember
2024-01-01
2024-09-30

0001468328
us-gaap:OperatingSegmentsMember
us-gaap:GeneralAndAdministrativeExpenseMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PrivatePayMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PrivatePayMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PrivatePayMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PrivatePayMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HospiceSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HospiceSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HospiceSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:HospiceSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:HospiceSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:CommercialInsuranceMember
adus:HospiceSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HospiceSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HospiceSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HospiceSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HospiceSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HospiceSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HospiceSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HospiceSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HospiceSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HospiceSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HomeHealthSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HomeHealthSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:MedicareMember
adus:HomeHealthSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HomeHealthSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HomeHealthSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:ManagedCareOrganizationsMember
adus:HomeHealthSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMember
adus:HomeHealthSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMember
adus:HomeHealthSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMember
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMember
adus:HomeHealthSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HomeHealthSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HomeHealthSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:OtherMember
adus:HomeHealthSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HomeHealthSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HomeHealthSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:CustomerConcentrationRiskMember
adus:HomeHealthSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:IL
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:IL
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:IL
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:IL
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NM
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NM
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NM
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NM
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NY
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NY
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NY
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:NY
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:TX
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:TX
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:TX
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
stpr:TX
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
adus:AllOtherStatesMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
adus:AllOtherStatesMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
adus:AllOtherStatesMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
adus:AllOtherStatesMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:PersonalCareSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:OH
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:OH
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:OH
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:OH
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:IL
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:IL
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:IL
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:IL
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:NM
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:NM
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:NM
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
stpr:NM
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
adus:AllOtherStatesMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
adus:AllOtherStatesMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
adus:AllOtherStatesMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
adus:AllOtherStatesMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HospiceSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:NM
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:NM
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:NM
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:NM
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:TN
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:TN
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:TN
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:TN
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:IL
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:IL
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:IL
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
stpr:IL
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
adus:AllOtherStatesMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
adus:AllOtherStatesMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
adus:AllOtherStatesMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
adus:AllOtherStatesMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:GeographicConcentrationRiskMember
adus:HomeHealthSegmentMember
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:GeographicConcentrationRiskMember
stpr:IL
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:GeographicConcentrationRiskMember
stpr:IL
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:GeographicConcentrationRiskMember
stpr:IL
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:GeographicConcentrationRiskMember
stpr:IL
2024-01-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
stpr:IL
2025-07-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
stpr:IL
2024-07-01
2024-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
stpr:IL
2025-01-01
2025-09-30

0001468328
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
stpr:IL
2024-01-01
2024-09-30

0001468328
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
stpr:IL
2025-01-01
2025-09-30

0001468328
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
stpr:IL
2024-01-01
2024-12-31

0001468328
adus:GoldHorsesLLCMember
us-gaap:SubsequentEventMember
2025-10-01
2025-10-01

0001468328
adus:WBradleyBickhamMember
2025-07-01
2025-09-30

0001468328
adus:WBradleyBickhamMember
2025-09-30

0001468328
adus:WBradleyBickham2Member
2025-07-01
2025-09-30

0001468328
adus:WBradleyBickham3Member
2025-07-01
2025-09-30

0001468328
adus:WBradleyBickham2Member
2025-09-30

0001468328
adus:WBradleyBickham3Member
2025-09-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 
10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended 
September 30, 2025

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to              

Commission file number 
001-34504

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

20-5340172

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

6303 Cowboys Way, Suite 600

Frisco
, 
TX

75034

(Address of principal executive offices)

(Zip Code)

(
469
) 
535-8200

(Registrant
’
s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

ADUS

The 
Nasdaq
 Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes
 ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes
 ☒ No ☐

    1

Table of Contents

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-Accelerated Filer

☐

Smaller Reporting Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes 
☐
 No ☒

As of October 28, 2025, Addus HomeCare Corporation had 
18,483,271

shares of Common Stock outstanding.

    2

Table of Contents

ADDUS HOMECARE CORPORATION

FORM 10-Q

INDEX

PART I. FINANCIAL INFORMATION

4

Item 1. Financial Statements (Unaudited)

4

Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 

4

Condensed Consolidated Statements of Income For the Three and Nine Months Ended September 30, 2025 and 2024

5

Condensed Consolidated Statement of Stockholders
’
 Equity For the Three and Nine Months Ended September 30, 2025 and 2024

6

Condensed Consolidated Statements of Cash Flows For the Nine Months Ended September 30, 2025 and 2024

8

Notes to Condensed Consolidated Financial Statements 

9

Item 2. Management
’
s Discussion and Analysis of Financial Condition and Results of Operations

25

Item 3. Quantitative and Qualitative Disclosures About Market Risk

43

Item 4. Controls and Procedures

43

PART II. OTHER INFORMATION

44

Item 1. Legal Proceedings

44

Item 1A. Risk Factors

44

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

44

Item 3. Defaults Upon Senior Securities

44

Item 4. Mine Safety Disclosures

44

Item 5. Other Information

45

Item 6. Exhibits

46

        3

Table of Contents

PART I 
–
 FINANCIAL INFORMATION

Item 1.         Financial Statements

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of September 30, 2025 and December 31, 2024

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

September 30, 2025

December 31, 2024

Assets

Current assets

Cash

$
101,918

$
98,911

Accounts receivable, net of allowances

134,050

122,880

Prepaid expenses and other current assets

24,693

38,591

Total current assets

260,661

260,382

Property and equipment, net of accumulated depreciation and amortization

24,444

24,703

Other assets

Goodwill

988,553

970,558

Intangibles, net of accumulated amortization

104,401

109,643

Operating lease assets, net

44,879

47,348

Total other assets

1,137,833

1,127,549

Total assets

$
1,422,938

$
1,412,634

Liabilities and stockholders' equity

Current liabilities

Accounts payable

$
16,677

$
27,176

Accrued payroll

74,131

62,053

Accrued expenses

32,942

28,959

Operating lease liabilities, current portion

13,031

12,800

Government stimulus advances

5,784

11,239

Accrued workers' compensation insurance

14,233

13,644

Total current liabilities

156,798

155,871

Long-term liabilities

Long-term debt, less current portion, net of debt issuance costs

150,640

218,443

Long-term operating lease liabilities

38,814

41,883

Deferred income tax

26,476

25,820

Other long-term liabilities

236

125

Total long-term liabilities

216,166

286,271

Total liabilities

$
372,964

$
442,142

Stockholders' equity

Common stock—$
.001
 par value; 
40,000
 authorized and 
18,483
 and 
18,148
 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

$
18

$
18

Additional paid-in capital

607,398

594,044

Retained earnings

442,558

376,430

Total stockholders' equity

1,049,974

970,492

Total liabilities and stockholders' equity

$
1,422,938

$
1,412,634

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

       4

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three and Nine Months Ended September 30, 2025 and 2024

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

For the Three Months Ended

For the Nine Months Ended

September 30,

September 30,

2025

2024

2025

2024

Net service revenues

$
362,301

$
289,787

$
1,049,452

$
857,455

Cost of service revenues

245,586

197,583

711,183

583,916

Gross profit

116,715

92,204

338,269

273,539

General and administrative expenses

79,370

62,805

229,667

187,444

Depreciation and amortization

4,408

3,446

12,264

10,316

Total operating expenses

83,778

66,251

241,931

197,760

Operating income

32,937

25,953

96,338

75,779

Interest income

(
760
)

(
1,908
)

(
1,845
)

(
2,805
)

Interest expense

3,343

573

10,886

5,445

Total interest expense, net

2,583

(
1,335
)

9,041

2,640

Income before income taxes

30,354

27,288

87,297

73,139

Income tax expense

7,506

7,125

21,169

19,067

Net income

$
22,848

$
20,163

$
66,128

$
54,072

Net income per common share

Basic income per share

$
1.26

$
1.13

$
3.67

$
3.24

Diluted income per share

$
1.24

$
1.10

$
3.60

$
3.17

Weighted average number of common shares and potential common shares outstanding:

Basic

18,072

17,868

18,031

16,707

Diluted

18,390

18,255

18,365

17,065

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

       5

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Nine Months Ended September 30, 2025

(Amounts and Shares in Thousands)

(Unaudited)

For the Three Months Ended September 30, 2025

Additional

Total

Common Stock

Paid-in

Retained

Stockholders'

Shares

Amount

Capital

Earnings

Equity

Balance at July 1, 2025

18,407

$
18

$
602,126

$
419,710

$
1,021,854

Issuance of shares of common stock under restricted stock award agreements

28

—

—

—

—

Forfeiture of shares of common stock under restricted stock award agreements

(
2
)

—

—

—

—

Stock-based compensation

—

—

4,287

—

4,287

Shares issued for exercise of stock options

50

—

985

—

985

Net income

—

—

—

22,848

22,848

Balance at September 30, 2025

18,483

$
18

$
607,398

$
442,558

$
1,049,974

For the Nine Months Ended September 30, 2025

Additional

Total

Common Stock

Paid-in

Retained

Stockholders'

Shares

Amount

Capital

Earnings

Equity

Balance at January 1, 2025

18,148

$

18

$

594,044

$

376,430

$

970,492

Issuance of shares of common stock under restricted stock award agreements

265

—

—

—

—

Forfeiture of shares of common stock under restricted stock award agreements

(
5

)

—

—

—

—

Stock-based compensation

—

—

11,877

—

11,877

Shares issued for exercise of stock options

75

—

1,477

—

1,477

Net income

—

—

—

66,128

66,128

Balance at September 30, 2025

18,483

$

18

$

607,398

$

442,558

$

1,049,974

       6

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Nine Months Ended September 30, 2024

(Amounts and Shares in Thousands)

(Unaudited)

For the Three Months Ended September 30, 2024

Additional

Total

Common Stock

Paid-in

Retained

Stockholders'

Shares

Amount

Capital

Earnings

Equity

Balance at July 1, 2024

18,100

$

18

$

584,896

$

336,741

$

921,655

Issuance of shares of common stock under restricted stock award agreements

—

—

—

—

—

Forfeiture of shares of common stock under restricted stock award agreements

(
2

)

—

—

—

—

Stock-based compensation

—

—

2,833

—

2,833

Shares issued for exercise of stock options

35

—

2,983

—

2,983

Shares issued in Public offering, net of offering costs

—

—

—

—

—

Net income

—

—

—

20,163

20,163

Balance at September 30, 2024

18,133

$

18

$

590,712

$

356,904

$

947,634

For the Nine Months Ended September 30, 2024

Additional

Total

Common Stock

Paid-in

Retained

Stockholders'

Shares

Amount

Capital

Earnings

Equity

Balance at January 1, 2024

16,227

$

16

$

403,846

$

302,832

$

706,694

Issuance of shares of common stock under restricted stock award agreements

151

—

—

—

—

Forfeiture of shares of common stock under restricted stock award agreements

(
5

)

—

—

—

—

Stock-based compensation

—

—

8,307

—

8,307

Shares issued for exercise of stock options

35

—

2,983

—

2,983

Shares issued in Public offering, net of offering costs

1,725

2

175,576

—

175,578

Net income

—

—

—

54,072

54,072

Balance at September 30, 2024

18,133

$

18

$

590,712

$

356,904

$

947,634

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

       7

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30, 2025 and 2024

(Amounts in Thousands)

(Unaudited)

For the Nine Months Ended

September 30,

2025

2024

Cash flows from operating activities:

Net income

$
66,128

$
54,072

Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:

Depreciation and amortization

12,264

10,316

Deferred income taxes

656

188

Stock-based compensation

11,877

8,307

Amortization of debt issuance costs under the credit facility

967

644

Provision for credit losses

1,048

812

Gain on disposal of assets

(
6
)

(
13
)

Loss on termination of operating leases

23

9

Changes in operating assets and liabilities, net of acquisitions:

Accounts receivable

(
8,513
)

17,868

Prepaid expenses and other current assets

9,848

6,187

Government stimulus advances

(
5,455
)

7,890

Accounts payable

(
12,204
)

1,003

Accrued payroll

11,439

1,431

Accrued expenses and other long-term liabilities

4,672

(
2,698
)

Net cash provided by operating activities

92,744

106,016

Cash flows from investing activities:

Acquisitions of businesses, net of cash acquired

(
24,181
)

(
400
)

Purchases of property and equipment

(
5,056
)

(
4,353
)

Proceeds received from disposal of assets

8

29

Proceeds received from previous acquisition

2,937

—

Proceeds received from divestiture of business

3,848

4,600

Net cash used in investing activities

(
22,444
)

(
124
)

Cash flows from financing activities:

Payments on revolver — credit facility

(
80,000
)

(
126,353
)

Proceeds from borrowings on revolver — credit facility

11,335

—

Payments for debt issuance costs under the credit facility

(
105
)

(
39
)

Proceeds from Public offering

—

175,578

Cash received from exercise of stock options

1,477

2,983

Net cash (used in) provided by financing activities

(
67,293
)

52,169

Net change in cash

3,007

158,061

Cash, at beginning of period

98,911

64,791

Cash, at end of period

$
101,918

$
222,852

Supplemental disclosures of cash flow information:

Cash paid for interest

$
10,071

$
4,801

Cash paid for income taxes

9,240

19,436

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

       8

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.
 Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of 
three
 distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who 
 may 
require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 
10
-Q. The accompanying balance sheet as of 
 December 31, 2024
 has been derived from the Company’s audited financial statements for the year ended 
 December 31, 2024
 previously filed with the SEC. Accordingly, these financial statements do 
not
 include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended 
 December 31, 2024
 included in our Annual Report on Form 
10
-K, which includes information and disclosures 
not
 included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are 
not
 necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

2.
 Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

9

Table of Contents

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

(Amounts in thousands)

(Amounts in thousands)

2025

2024

2025

2024

Weighted average number of shares outstanding for basic per share calculation

18,072

17,868

18,031

16,707

Effect of dilutive potential shares:

Stock options

210

278

217

254

Restricted stock awards

108

109

117

104

Adjusted weighted average shares for diluted per share calculation

18,390

18,255

18,365

17,065

Anti-dilutive shares:

Stock options

—

—

—

—

Restricted stock awards

—

—

—

—

Recently Adopted Accounting Pronouncements

In 
 November 2023, 
the Financial Accounting Standards Board (“FASB”) issued ASU 
2023
-
07,

Improvements to Reportable Segment Disclosures
, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity’s chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU was adopted in connection with the Company's most recent Annual Report on Form 
10
-K, which included significant segment expenses reviewed by the Company’s CODM, but did 
not
 have a material impact on the Company’s results of operations, financial position, or cash flows.

Recently Issued Accounting Pronouncements

In 
 December 2023, 
the FASB issued ASU 
2023
-
09,

Improvement to Income Tax Disclosures
, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 
2023
-
09
 is effective for fiscal years beginning after 
 December 15, 2024, 
 may 
be applied on a prospective basis with the option to apply the standard retrospectively, and allows for early adoption. These requirements are 
not
 expected to have a material impact on the Company’s financial statements and will expand income tax disclosures.

In 
 November 2024, 
the FASB issued ASU 
2024
-
03,

Disaggregation of Income Statement Expenses
, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 
2024
-
03
 is effective for fiscal years beginning after 
 December 15, 2026, 
and interim periods within fiscal years beginning after 
 December 15, 2027, 
with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

In 
 July 2025, 
the FASB issued ASU 
2025
-
05,

Measurement of Credit Losses for Accounts Receivable and Contract Assets
, which replaces the incurred-loss model with a forward-looking current expected credit loss model that requires recognition of lifetime expected credit losses on financial assets measured at amortized cost and certain off-balance-sheet credit exposures (including trade accounts receivable and contract assets), using historical experience, current conditions, and reasonable and supportable forecasts. ASU 
2025
-
05
 is effective for annual reporting periods beginning after 
 December 15, 2025, 
and interim reporting periods within those annual reporting periods, with early adoption permitted. The disclosure updates should be applied prospectively. The Company is currently assessing the impact and timing of adopting the updated provisions.

10

Table of Contents

3.
 Divestiture

Effective 
 May 20, 2024, 
the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $
23.0
 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 
50
% cash consideration, paid out as an initial payment of $
4.6
 million and $
6.9
 million paid pro rata as a deferred payment as caregivers are transferred, and 
50
% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. The Company entered into a consulting agreement with the purchaser effective 
 May 20, 2024, 
as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. The Company determined that the consulting agreement gave it the ability to control the business until 
 October 2024, 
when the Company determined that it 
no
 longer controlled the business as it transferred more than 
50
% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $
3.7
 million during the year ended 
 December 31, 2024. 
The gain was reflected within general and administrative expenses on the consolidated statement of operations.

In connection with this transaction, the Company ceased operations in New York. During the 
nine
 months ended 
 September 30, 2025
, the Company recorded deferred payments of 
$
3.8

million with the remaining 
$
2.3

million due from the purchaser reflected within prepaid expenses and other current assets on the condensed consolidated balance sheets as of 
 September 30, 2025
. 
No
 amount was recorded related to the CDPAP business contingent consideration.

The New York Asset Sale did 
not
 qualify as a discontinued operation because it did 
not
 represent a strategic shift that has or will have a major effect on the Company’s operation or financial results.

Goodwill and intangible assets of $
2.9
 million and $
4.2
 million, respectively, were derecognized in connection with the divestiture. The carrying amounts of the assets and liabilities associated with the New York personal care operations included in our Consolidated Balance Sheets as of 
 September 30, 2025
 were as follows (amounts in thousands):

September 30, 2025

Assets

Current assets

Accounts receivable, net of allowances

$
—

Prepaid expenses and other current assets

12

Total current assets

12

Property and equipment, net of accumulated depreciation and amortization

—

Other assets

Goodwill

—

Intangibles, net of accumulated amortization

—

Operating lease assets, net

2,724

Total other assets

2,724

Total assets

$
2,736

Liabilities

Current liabilities

Accounts payable

$
1,150

Accrued payroll

—

Accrued expenses

1,045

Operating lease liabilities, current portion

618

Total current liabilities

2,813

Long-term liabilities

Operating lease liabilities, long-term portion

2,043

Total liabilities

$
4,856

11

Table of Contents

4.
 Leases 

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

September 30, 2025

December 31, 2024

(Amounts in Thousands)

Operating lease assets, net

$
44,879

$
47,348

Short-term operating lease liabilities

13,031

12,800

Long-term operating lease liabilities

38,814

41,883

Total operating lease liabilities

$
51,845

$
54,683

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

(Amounts in Thousands)

(Amounts in Thousands)

2025

2024

2025

2024

Operating lease costs

$
3,623

$
3,393

$
10,931

$
10,062

Short-term lease costs

292

167

847

547

Total lease costs

3,915

3,560

11,778

10,609

Less: sublease income

—

(
596
)

(
226
)

(
1,685
)

Total lease costs, net

$
3,915

$
2,964

$
11,552

$
8,924

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

September 30, 2025

December 31, 2024

Operating leases:

Weighted average remaining lease term

5.22

5.48

Weighted average discount rate

6.37
%

6.20
%

12

Table of Contents

Maturity of Lease Liabilities

Remaining operating lease payments as of 
 September 30, 2025
 were as follows:

Operating Leases

(Amounts in Thousands)

Due in the 12-month period ended September 30,

2026

$
15,759

2027

12,614

2028

9,143

2029

6,946

2030

6,016

Thereafter

11,064

Total future minimum rental commitments

61,542

Less: Imputed interest

(
9,697
)

Total lease liabilities

$
51,845

Supplemental Cash Flows Information

For the Nine Months Ended September 30,

(Amounts in Thousands)

2025

2024

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases

$
12,505

$
10,925

Right-of-use assets obtained in exchange for lease obligations:

Operating leases

$
7,156

$
7,683

5.
 Acquisitions

The Company’s acquisitions have been accounted for in accordance with ASC Topic 
805,

Business Combinations
,

and the resulting goodwill and other intangible assets were accounted for under ASC Topic 
350,

Goodwill and Other Intangible Assets
. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Unaudited Condensed Consolidated Statements of Income from the date of acquisition.

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

13

Helping Hands

On 
 August 1, 2025, 
the Company completed the acquisition of Helping Hands Home Care Service, Inc., a Pennsylvania corporation (the “Helping Hands Acquisition”), for approximately $
21.4
 million. The purchase was funded through the Company’s revolving credit facility and available cash. With the Helping Hands Acquisition, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania. The related acquisition and integration costs were $
0.3
 million and $
0.1
 million for the 
three
 months ended 
 September 30, 2025, 
and $
0.9
 million and $
0.1
 million for the 
nine
 months ended 
 September 30, 2025, 
respectively. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Total (Amounts in Thousands)

Goodwill

$
19,022

Identifiable intangible assets

1,150

Cash

584

Accounts receivable

1,365

Property and equipment

19

Operating lease assets, net

282

Other current assets

45

Accounts payable

(
98
)

Accrued payroll

(
697
)

Operating lease liabilities, total

(
257
)

Total purchase price

$
21,415

Identifiable intangible assets acquired included $
1.2
 million of definite-lived state licenses. The preliminary estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 
3
 inputs as defined under ASC Topic 
820.
 The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Helping Hands Acquisition accounted for $
3.1
 million of net service revenues and $
0.4
 million of operating income for each of the 
three
 and 
nine
 months ended 
 September 30, 2025, 
respectively.

The following table contains unaudited pro forma condensed consolidated income statement information of the Company for the 
three
 and 
nine
 months ended 
 September 30, 2025 
as if the Helping Hands Acquisition closed on 
 January 1, 2024.

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

(Amounts in Thousands)

(Amounts in thousands)

2025

2024

2025

2024

Net service revenues

$
364,001

$
293,804

$
1,060,396

$
868,481

Operating income

32,153

26,486

97,372

76,915

Net income

22,327

20,555

67,120

54,908

Net income per common share

Basic income per share

$
1.24

$
1.15

$
3.72

$
3.29

Diluted income per share

$
1.21

$
1.13

$
3.65

$
3.22

14

6.
 Goodwill and Intangible Assets

A summary of the goodwill by segment and related adjustments is provided below:

Home

Hospice

Personal Care

Health

Total

(Amounts in Thousands)

Goodwill as of December 31, 2024

$
432,840

$
442,526

$
95,192

$
970,558

Additions for acquisitions

—

22,407

—

22,407

Adjustments to previously recorded goodwill

26

(
4,096
)

(
342
)

(
4,412
)

Goodwill as of September 30, 2025

$
432,866

$
460,837

$
94,850

$
988,553

On 
 January 1, 2025, 
the Company completed its acquisition of its Jacksonville affiliate for approximately $
0.8
 million (the “Jacksonville Acquisition”), with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $
0.8
 million.

On 
 March 1, 2025, 
the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC for $
2.6
 million (the “Great Lakes Acquisition”), with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $
2.6
 million.

In connection with the Helping Hands Acquisition, the Company recognized goodwill in its personal care segm
ent of $
19.1

million during the ni
ne months ended 
 September 30, 2025.

During the 
three
 and 
nine
 months ended 
 September 30, 2025
, the Company recorded 
$
0.3
 million and $
4.4
 million, respectively, related to measurement period adjustments to previously recorded goodwill including $
2.9
 million of proceeds received in connection with the Gentiva Acquisition. 

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from 
one
 to 
twenty
 years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from 
three
 to 
fifteen
 years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

September 30, 2025

December 31, 2024

(Amounts in Thousands)

(Amounts in Thousands)

Estimated Useful

Gross

Accumulated

Net

Gross

Accumulated

Net

Life (years)

carrying value

amortization

carrying value

carrying value

amortization

carrying value

Customer and referral relationships

3
 - 
15

$
34,201

$
(
33,559
)

$
642

$
34,201

$
(
33,255
)

$
946

Trade names and trademarks

1
 - 
20

59,366

(
25,376
)

33,990

59,366

(
21,900
)

37,466

Non-competition agreement

3
 - 
5

6,728

(
6,582
)

146

6,728

(
6,263
)

465

State Licenses

6
 - 
10

26,529

(
3,536
)

22,993

24,981

(
1,243
)

23,738

State Licenses

Indefinite

46,630

—

46,630

47,028

—

47,028

Total intangible assets

$
173,454

$
(
69,053
)

$
104,401

$
172,304

$
(
62,661
)

$
109,643

15

Table of Contents

In connection with the Helping Hands Acquisition, the Company recognized state licenses of $
1.2
 million in its personal care segment during the 
nine
 months ended 
 September 30, 2025.

Amortization expense related to the intangible assets was 
$
2.4
 million and

$
6.4
 million for the 
three
 and 
nine
 months ended 
 September 30, 2025
, respectively, and 
$
1.8
 million
 and $
5.4
 million for the 
three
 and 
nine
 months ended 
 September 30, 2024
, respectively. The weighted average remaining useful lives of identifiable intangible assets as of 
 September 30, 2025
 was 
9.28
 years.

7.
 Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

September 30, 2025

December 31, 2024

(Amounts in Thousands)

Income tax receivable

$
2,255

$
11,568

Prepaid payroll

5,506

8,716

Prepaid workers' compensation and liability insurance

5,323

4,254

Prepaid licensing fees

4,874

5,414

Workers' compensation insurance receivable

804

810

Other 
(1)

5,931

7,829

Total prepaid expenses and other current assets

$
24,693

$
38,591

(
1
)

Included $
2.3
 million and $
6.1
 million related to the New York Asset Sale deferred payments as of 
 September 30, 2025
 and 
 December 31, 2024
, respectively.

Accrued expenses consisted of the following:

September 30, 2025

December 31, 2024

(Amounts in Thousands)

Accrued health benefits

$
6,602

$
6,637

Accrued professional fees

6,151

5,368

Accrued payroll and other taxes

5,681

4,516

Other

14,508

12,438

Total accrued expenses

$
32,942

$
28,959

8.
 ARPA Spending Plans

To mitigate the fiscal effects of the COVID-
19
 public health emergency, the American Rescue Plan Act of 
2021
 (“ARPA”) provided for a 
10
-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from 
 April 1, 2021, 
through 
 March 31, 2022, 
provided the states satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through 
 March 31, 2025, 
but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-
2026.
 States must use the monies attributable to this matching fund increase to supplement, 
not
 supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of 
 April 1, 2021.

16

Table of Contents

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds 
 may 
be subject to recoupment if 
not
 expended or if they are expended on non-approved uses.

During the 
three
 and 
nine
 months ended 
 September 30, 2025
, the Company did 
not
 receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through 
 September 30, 2025
, the Company utilized 
$
2.2
 million and 
$
5.5
 million during the 
three
 and 
nine
 months ended 
 September 30, 2025
, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of 
 September 30, 2025
, the deferred portion of ARPA funding of 
$
5.8
 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

9.
 Long-Term Debt

Long-term debt consisted of the following:

September 30, 2025

December 31, 2024

(Amounts in Thousands)

Revolving loan under the credit facility

$
154,335

$
223,000

Less unamortized issuance costs

(
3,695
)

(
4,557
)

Long-term debt

$
150,640

$
218,443

Amended and Restated Senior Secured Credit Facility

On 
 October 31, 2018, 
the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of 
 September 12, 2019, 
as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of 
 July 30, 2021, 
as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of 
 April 26, 2023, 
and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of 
 October 22, 2024 (
as described below, the “Fourth Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 
10
-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $
650.0
 million revolving credit facility and a $
150.0
 million incremental loan facility, which incremental loan facility 
 may 
be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is 

July 30, 2028
.

On 
 October 22, 2024, 
the Company entered into the Fourth Amendment to, among other things, (a) increase the Company’s revolving credit facility to an aggregate amount of 
$
650.0

million, (b) increase the Company’s incremental loan facility to an aggregate amount of $
150.0
 million, and (c) extend the maturity date of the credit facility from 
 July 30, 2026 
to 

July 30, 2028
.

17

Table of Contents

Interest on the credit facility 
 may 
be payable at (
x
) the sum of (i) an applicable margin ranging from 
0.75
% to 
1.50
% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 
0.50
%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administrative Limited) for an interest period of 
one
 month for such applicable day (
not
 to be less than 
0.00
%), plus a margin of 
1.00
% or (y) the sum of (i) an applicable margin ranging from 
1.75
% to 
2.50
% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period (
not
 to be less than 
0.00
%). Swing loans 
 may 
not
 be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a 
first
 priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) 
not
 exceeding 
3.75:1.00.
 In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 
4.25:1.00
 for the then current fiscal quarter and the 
three
 succeeding fiscal quarters.

The Company pays a fee ranging from 
0.20
% to 
0.35
% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property, and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments, and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare 
 may 
make distributions to the Company in an amount that does 
not
 exceed $
10.0
 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

During the 
nine
 months ended 
 September 30, 2025
, 
the Company (i) drew approximately 
$11.3
 million under its credit facility to fund, in part, the Helping Hands Acquisition, and (ii) repaid $
80.0
 million under the revolving credit facility.

As of 
 September 30, 2025
, 
the Company had a total of $
154.3
 million of revolving loans, with an interest rate of 
5.92
%, outstanding on its credit facility. 
After giving effect to the amount drawn on its credit facility, approximately 
$
7.9
 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement),
 the Company had $
650.0
 million of capacity and $
487.7
 million available for borrowing under its credit facility. 
As of 
 December 31, 2024
, the Company had a total of $
223.0
 million of revolving loans, with an interest rate of 
6.34
%, outstanding on its credit facility.

As of 
 September 30, 2025
, the Company was in compliance with all financial covenants under the Credit Agreement.

18

Table of Contents

10.
 Income Taxes

The effective income tax rates were 
24.7
%
 and 
26.1
% for the 
three
 months ended 
 September 30, 2025 
and 
2024
, respectively. The effective income tax rates were 
24.3
%
 and 
26.1
% for the 
nine
 months ended 
 September 30, 2025 
and 
2024
, respectively.

For the 
three
 months ended 
 September 30, 2025
, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, partially offset by the use of federal employment tax credits and an excess tax benefit. For both the 
three
 months ended 
 September 30, 2025 
and 
2024
, the effective tax rates were inclusive of an excess tax benefit of 
3.6
% and 
0.5
%
, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

11.
 Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will 
not
 have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

12.
 Segment Information

Operating segments are defined as components of a company that engage in business activities from which it 
 may 
earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s CODM. The Company identifies its 
Chief Executive Officer and Chief Operating Officer
 together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of 
three
 business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who 
 may 
require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore 
not
 attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

The CODMs do 
not
 review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

19

Table of Contents

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

For the Three Months Ended September 30, 2025

(Amounts in Thousands)

Personal Care

Hospice

Home Health

Total

Net service revenues

$
275,770

$
68,891

$
17,640

$
362,301

Direct service personnel

199,656

28,287

10,155

238,098

General and administrative salaries, wages and benefits

18,629

11,658

3,538

33,825

Other segment items 
1

6,395

10,131

1,400

17,926

Segment operating income

51,090

18,815

2,547

72,452

Segment reconciliation:

Items not allocated at segment level:

Other general and administrative expenses

35,107

Depreciation and amortization

4,408

Interest income

(
760
)

Interest expense

3,343

Income before income taxes

$
30,354

(
1
)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

For the Three Months Ended September 30, 2024

(Amounts in Thousands)

Personal Care

Hospice

Home Health

Total

Net service revenues

$
215,433

$
57,309

$
17,045

$
289,787

Direct service personnel

156,072

24,791

10,513

191,376

General and administrative salaries, wages and benefits

11,949

10,556

3,553

26,058

Other segment items 
1

5,741

9,192

1,113

16,046

Segment operating income

41,671

12,770

1,866

56,307

Segment reconciliation:

Items not allocated at segment level:

Other general and administrative expenses

26,908

Depreciation and amortization

3,446

Interest income

(
1,908
)

Interest expense

573

Income before income taxes

$
27,288

(
1
)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

20

Table of Contents

For the Nine Months Ended September 30, 2025

(Amounts in Thousands)

Personal Care

Hospice

Home Health

Total

Net service revenues

$
803,238

$
192,540

$
53,674

$
1,049,452

Direct service personnel

579,174

80,670

30,019

689,863

General and administrative salaries, wages and benefits

55,276

34,085

9,846

99,207

Other segment items 
1

18,468

29,531

3,866

51,865

Segment operating income

150,320

48,254

9,943

208,517

Segment reconciliation:

Items not allocated at segment level:

Other general and administrative expenses

99,915

Depreciation and amortization

12,264

Interest income

(
1,845
)

Interest expense

10,886

Income before income taxes

$
87,297

(
1
)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

For the Nine Months Ended September 30, 2024

(Amounts in Thousands)

Personal Care

Hospice

Home Health

Total

Net service revenues

$
636,253

$
169,202

$
52,000

$
857,455

Direct service personnel

460,587

71,580

31,967

564,134

General and administrative salaries, wages and benefits

35,049

30,601

10,893

76,543

Other segment items 
1

15,835

27,960

3,773

47,568

Segment operating income

124,782

39,061

5,367

169,210

Segment reconciliation:

Items not allocated at segment level:

Other general and administrative expenses

83,115

Depreciation and amortization

10,316

Interest income

(
2,805
)

Interest expense

5,445

Income before income taxes

$
73,139

(
1
)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

21

Table of Contents

13.
 Significant Payors

The Company’s revenue by payor type was as follows:

Personal Care Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

State, local and other governmental programs

$
139,383

50.5
%

$
116,702

54.2
%

$
410,781

51.1
%

$
337,458

53.0
%

Managed care organizations

127,293

46.2

93,321

43.3

366,210

45.6

281,732

44.3

Private pay

7,064

2.5

3,599

1.7

21,331

2.7

11,194

1.8

Commercial insurance

1,860

0.7

1,415

0.7

4,356

0.5

4,368

0.7

Other

170

0.1

396

0.1

560

0.1

1,501

0.2

Total personal care segment net service revenues

$
275,770

100.0
%

$
215,433

100.0
%

$
803,238

100.0
%

$
636,253

100.0
%

Hospice Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

Medicare

$
64,148

93.1
%

$
52,413

91.5
%

$
178,784

92.9
%

$
154,187

91.1
%

Commercial insurance

2,140

3.1

2,892

5.0

6,518

3.4

8,870

5.2

Managed care organizations

2,216

3.2

1,821

3.2

6,245

3.2

5,518

3.3

Other

387

0.6

183

0.3

993

0.5

627

0.4

Total hospice segment net service revenues

$
68,891

100.0
%

$
57,309

100.0
%

$
192,540

100.0
%

$
169,202

100.0
%

22

Table of Contents

Home Health Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

Medicare

$
11,617

65.9
%

$
12,036

70.6
%

$
36,711

68.4
%

$
36,216

69.6
%

Managed care organizations

4,492

25.5

4,215

24.7

12,564

23.4

13,291

25.6

State, local and other governmental programs (excluding Medicare)

993

5.6

(
17
)

—

2,878

5.3

—

—

Other

538

3.0

811

4.7

1,521

2.9

2,493

4.8

Total home health segment net service revenues

$
17,640

100.0
%

$
17,045

100.0
%

$
53,674

100.0
%

$
52,000

100.0
%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states and New York for the 
three
 and 
nine
 months ended 
 September 30, 2025 
and 
2024
, respectively, were as follows:

Personal Care Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

Illinois

$
115,989

42.1
%

$
111,916

51.9
%

$
342,629

42.7
%

$
330,265

51.9
%

New Mexico

30,029

10.9

28,962

13.4

87,320

10.9

86,573

13.6

New York
(1)

(
318
)

—

21,406

9.9

(
104
)

—

68,239

10.7

Texas

53,449

19.4

—

—

155,773

19.4

—

—

All other states

76,621

27.6

53,149

24.8

217,620

27.0

151,176

23.8

Total personal care segment net service revenues

$
275,770

100.0
%

$
215,433

100.0
%

$
803,238

100.0
%

$
636,253

100.0
%

(
1
)

As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations 
no
 longer fit its growth strategy and is divesting these operations. See Note 
3
 to the Notes to Unaudited Condensed Consolidated Financial Statements, 
Divestiture
,

for additional details regarding our divestiture.

23

Table of Contents

Hospice Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

Ohio

$
26,913

39.1
%

$
21,531

37.6
%

$
73,304

38.1
%

$
62,400

36.9
%

Illinois

15,532

22.5

13,289

23.2

44,516

23.1

38,544

22.8

New Mexico

8,769

12.7

6,951

12.1

24,865

12.9

21,361

12.6

All other states

17,677

25.7

15,538

27.1

49,855

25.9

46,897

27.7

Total hospice segment net service revenues

$
68,891

100.0
%

$
57,309

100.0
%

$
192,540

100.0
%

$
169,202

100.0
%

Home Health Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

New Mexico

$
8,644

49.0
%

$
8,090

47.4
%

$
25,937

48.3
%

$
24,166

46.5
%

Tennessee

6,852

38.8

6,542

38.4

21,672

40.4

19,437

37.4

Illinois

1,759

10.0

2,413

14.2

5,680

10.6

8,397

16.1

All other states

385

2.2

—

—

385

0.7

—

—

Total home health segment net service revenues

$
17,640

100.0
%

$
17,045

100.0
%

$
53,674

100.0
%

$
52,000

100.0
%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 
32.0
% and 
38.6
% of our net service revenues for the 
three
 months ended 
 September 30, 2025 
and 
2024
, respectively, and accounted for 
32.6
% and 
38.5
% of our net service revenues for the 
nine
 months ended 
 September 30, 2025 
and 
2024
, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 
18.1
%
 and 
21.4
% of the Company’s net service revenues for the 
three
 months ended 
 September 30, 2025 
and 
2024
, respectively, and accounted for 
18.4
%
 and 
21.1
% of the Company’s net service revenues for the 
nine
 months ended 
 September 30, 2025 
and 
2024
, respectively.

The related receivables due from the Illinois Department on Aging represented 
16.6
%
 and 
21.7
% of the Company’s net accounts receivable at 
 September 30, 2025
 and 
 December 31, 2024
, respectively.

14.
 Subsequent Events

On 
 October 1, 2025
,
 the Company completed the acquisition of the assets of Gold Horses, LLC for approximately $
7.4
 million (the “Gold Horses Acquisition”). The purchase was funded through the Company’s available cash. The Gold Horses Acquisition expanded
 the Company
’
s services within its personal care segment in Texas. 
The initial accounting is 
not
 yet complete, and therefore the related business combination disclosures have 
not
 been presented as the Company is currently in the process of valuing the assets acquired and liabilities assumed in the transaction.

24

Table of Contents

ITEM 2.       MANAGEMENT
’
S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like 
“
believes,
”

“
belief,
”

“
expects,
”

“
plans,
”

“
anticipates,
”

“
intends,
”

“
projects,
”

“
estimates,
”

“
may,
”

“
might,
”

“
would,
”

“
should,
”
 and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including significant global inflation and interest rates, legislative and political developments, including federal government shutdowns, any lapse in appropriations and any hold on or cancellation of congressionally authorized spending or interruptions in the distribution of government funds, trade policies and tensions, including changes in, or the imposition of, tariffs and/or trade barriers and the economic impacts, volatility and uncertainty resulting therefrom, and the potential adverse effects of current conditions; business disruptions due to inclement weather, natural disasters, acts of terrorism, military conflicts, pandemics, civil insurrection or social unrest; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations
’
 policies and payment rates, and the timeliness of reimbursements received under government programs; the implementation of new, and possible changes to, existing, federal and state laws or regulations, or our failure to comply with such laws or regulations or comply on a timely basis; the impact of decisions of the U.S. Supreme Court regarding the actions of federal agencies; changes in presidential administrations; changes in the structure and administration of, and funding for, federal and state agencies and programs; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to overall economic conditions and deficit reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards and coverage limits imposed through legislation or by governmental agencies or other third-party payors; the potential for litigation, audits, and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating, and integrating acquisition opportunities and expanding into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality, and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates;

 and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December

31, 2024, filed with the SEC on February 25, 2025. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans, and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

       25

Table of Contents

Overview

We are a home care services provider operating three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 
37.0%
 and 34.3% of our net service revenues during the three months ended September 30, 2025 and 2024, respectively, and 
36.7%
 and 35.1% of our net service revenues during the nine months ended September 30, 2025 and 2024, respectively.

A summary of certain consolidated financial results is provided in the table below.

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

Net service revenues by segment:

(Amounts in Thousands)

(Amounts in Thousands)

Personal care

$

275,770

$

215,433

$

803,238

$

636,253

Hospice

68,891

57,309

192,540

169,202

Home health

17,640

17,045

53,674

52,000

Total net service revenue

$

362,301

$

289,787

$

1,049,452

$

857,455

Net income

$

22,848

$

20,163

$

66,128

$

54,072

As of September 30, 2025, we provided our services in 23 states through 
265
 offices. We served approximately 
96,000
 and 80,000 discrete individuals, respectively, during the nine months ended September 30, 2025 and 2024. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes, and hospice facilities.

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.

On March 9, 2024, we completed our acquisition of the operations of Upstate Home Care Solutions (“Upstate”) for $0.4 million, with funding provided by available cash. With the purchase of Upstate, the Company expanded its personal care segment in South Carolina.

On December 2, 2024, we completed the acquisition of the personal care business of Curo Health Services, LLC, a Delaware limited liability company that does business as Gentiva, consisting of certain equity interests and assets and liabilities (collectively, the “Gentiva Acquisition”) for approximatel
y $350.6 milli
on, with funding primarily provided by drawing on the Company’s revolving credit facility and a portion of the net proceeds of the Company’s public offering of common stock (the “Public Offering”). With the Gentiva Acquisition, the Company expanded its services within its personal care segment in Arizona, Arkansas, California, and North Carolina, and entered the market in Missouri and Texas. The home health segment also was expanded in Tennessee.

On January 1, 2025, the Company completed the Jacksonville Acquisition for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed the Great Lakes Acquisition for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

On August 1, 2025, the Company completed the Helping Hands Acquisition, for approximately $21.4 million, with funding through the Company’s revolving credit facility and available cash. With the purchase of Helping Hands, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania and recognized goodwill in its personal care segment of $19.0 million.

       26

Table of Contents

New York Asset Sale

Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. In connection with this transaction, the Company ceased operations in New York. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, 
Divesture
, for additional details regarding our divestiture.

Recruiting

As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be 
significant
. In addition, the United States economy continues to experience inflationary pressures. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.

Revenue by Payor and Significant States

Our payors are principally federal, state, and local governmental agencies and managed care organizations. The federal, state, and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We are experiencing a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

Our revenue by payor and significant states by segment were as follows:

Personal Care Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

State, local and other governmental programs

$

139,383

50.5

%

$

116,702

54.2

%

$

410,781

51.1

%

$

337,458

53.0

%

Managed care organizations

127,293

46.2

93,321

43.3

366,210

45.6

281,732

44.3

Private pay

7,064

2.5

3,599

1.7

21,331

2.7

11,194

1.8

Commercial insurance

1,860

0.7

1,415

0.7

4,356

0.5

4,368

0.7

Other

170

0.1

396

0.1

560

0.1

1,501

0.2

Total personal care segment net service revenues

$

275,770

100.0

%

$

215,433

100.0

%

$

803,238

100.0

%

$

636,253

100.0

%

Illinois

115,989

42.1

%

111,916

51.9

%

342,629

42.7

%

330,265

51.9

%

New Mexico

30,029

10.9

28,962

13.4

87,320

10.9

86,573

13.6

New York

(318

)

—

21,406

9.9

(104

)

—

68,239

10.7

Texas

53,449

19.4

—

—

155,773

19.4

—

—

All other states

76,621

27.6

53,149

24.8

217,620

27.0

151,176

23.8

Total personal care segment net service revenues

$

275,770

100.0

%

$

215,433

100.0

%

$

803,238

100.0

%

$

636,253

100.0

%

       27

Table of Contents

Hospice Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

Medicare

$

64,148

93.1

%

$

52,413

91.5

%

$

178,784

92.9

%

$

154,187

91.1

%

Commercial insurance

2,140

3.1

2,892

5.0

6,518

3.4

8,870

5.2

Managed care organizations

2,216

3.2

1,821

3.2

6,245

3.2

5,518

3.3

Other

387

0.6

183

0.1

993

0.5

627

0.4

Total hospice segment net service revenues

$

68,891

100.0

%

$

57,309

100.0

%

$

192,540

100.0

%

$

169,202

100.0

%

Ohio

$

26,913

39.1

%

$

21,531

37.6

%

$

73,304

38.1

%

$

62,400

36.9

%

Illinois

15,532

22.5

13,289

23.2

44,516

23.1

38,544

22.8

New Mexico

8,769

12.7

6,951

12.1

24,865

12.9

21,361

12.6

All other states

17,677

25.7

15,538

27.1

49,855

25.9

46,897

27.7

Total hospice segment net service revenues

$

68,891

100.0

%

$

57,309

100.0

%

$

192,540

100.0

%

$

169,202

100.0

%

Home Health Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

2025

2024

% of Segment

% of Segment

% of Segment

% of Segment

Amount

Net Service

Amount

Net Service

Amount

Net Service

Amount

Net Service

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

(in Thousands)

Revenues

Medicare

$

11,617

65.9

%

$

12,036

70.6

%

$

36,711

68.4

%

$

36,216

69.6

%

Managed care organizations

4,492

25.5

4,215

24.7

12,564

23.4

13,291

25.6

State, local and other governmental programs (excluding Medicare)

993

5.6

(17

)

—

2,878

5.3

—

—

Other

538

3.0

811

4.7

1,521

2.9

2,493

4.8

Total home health segment net service revenues

$

17,640

100.0

%

$

17,045

100.0

%

$

53,674

100.0

%

$

52,000

100.0

%

New Mexico

$

8,644

49.0

%

$

8,090

47.4

%

$

25,937

48.3

%

$

24,166

46.5

%

Tennessee

6,852

38.8

6,542

38.4

21,672

40.4

19,437

37.4

Illinois

1,759

10.0

2,413

14.2

5,680

10.6

8,397

16.1

All other states

385

2.2

—

—

385

0.7

—

—

Total home health segment net service revenues

$

17,640

100.0

%

$

17,045

100.0

%

$

53,674

100.0

%

$

52,000

100.0

%

The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 32.0%

and 38.6% of our net service revenues for the three months ended September 30, 2025 and 2024, respectively, and accounted for 32.6% and 38.5% of our net service revenues for the nine months ended September 30, 2025 and 2024, respectively.

       28

Table of Contents

A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 
18.1%
 and 21.4% of our net service revenues for the three months ended September 30, 2025 and 2024, respectively, and accounted for 
18.4%
 and 21.1% of our net service revenues for the nine months ended September 30, 2025 and 2024, respectively.

Changes in Illinois Reimbursement

The Illinois Medicaid omnibus legislation passed in June 2023 included an increase in hourly rates for in-home care services to $28.07, which took effect on January 1, 2024 and required a minimum wage rate of $17.00 per hour. CMS approved an amendment to the Illinois HCBS Waiver for Persons Who are Elderly, which included the rate increase for in-home care services to $28.07, effective January 1, 2024.

The Illinois fiscal year 2025 budget included an increase in hourly rates for in-home care services to $29.63, effective January 1, 2025, and required a minimum wage of $18.00 per hour for direct service workers. CMS approved an amendment to Illinois’ Persons Who are Elderly waiver program that included this rate increase, effective January 1, 2025.

The Illinois fiscal year 2026 budget includes an increase in hourly rates for in-home care services to $30.80, to take effect January 1, 2026, subject to federal approval. This rate sustains a minimum wage of $18.75 per hour for direct service workers.

The City of Chicago requires the Chicago minimum wage to be adjusted annually based on increases in the Consumer Price Index (“CPI”), subject to a cap and other requirements. Effective July 1, 2025, the rate was adjusted to $16.60 based on the increase in the CPI.

Our business will benefit from the rate increases noted above as planned for 2025, but there is no assurance that there will be additional rate increases in Illinois for fiscal years beyond fiscal year 2025 to offset increases to minimum wage, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

Changes in Texas Reimbursement

The Texas fiscal year 2026 budget includes an increase in hourly rates to $17.13 for in-home care services effective September 1, 2025.

Impact of Changes in Medicare and Medicaid Reimbursement

Hospice

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. The daily rate depends on the level of care provided to a patient (routine home care, continuous home care, inpatient respite care, or general inpatient care). Daily rates are adjusted for factors such as area wage levels. CMS updates hospice payment rates each federal fiscal year. Effective October 1, 2025, CMS increased hospice payment rates by 2.6%. This reflects a 3.3% market basket increase and a negative 0.7 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements are subject to a 4-percentage point reduction to the market basket update.

Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap. The inpatient cap limits the number of days of inpatient care for which Medicare will pay to no more than 20% of total patient care days. Days in excess of the limitation are paid at the routine home care rate. The aggregate cap limits the total Medicare reimbursement that a hospice may receive in a cap year (typically the federal fiscal year) based on an annual per-beneficiary cap amount, which is set each federal fiscal year, and the number of Medicare patients served. The per-beneficiary cap amount was updated to $35,361.44 for federal fiscal year 2026. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.

       29

Table of Contents

Home Health

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for the discipline providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.

CMS updates the HHPPS payment rates each calendar year. For calendar year 2025, CMS estimates that Medicare payments to home health agencies will increase by 0.5%. This is based on a home health payment update percentage of 2.7%, which reflects a 3.2% market basket update, reduced by a productivity adjustment of 0.5 percentage points, and an estimated 1.8% decrease associated with the transition to the PDGM, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.

Under the nationwide Home Health Value-Based Purchasing (“HHVBP”) Model, home health agencies receive increases or decreases to their Medicare fee-for-service payments of up to 5% based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later.

In certain states, payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program is currently limited to home health agencies in Illinois, Ohio, Oklahoma, North Carolina, Florida, and Texas. Providers in states subject to the Review Choice Demonstration for Home Health Services may initially select either pre-claim review or post-payment review. Home health agencies that maintain high compliance levels are eligible for additional options that may be less burdensome. This program has not had a material impact on our results of operations or financial position.

CMS Final Rule: 
“
Ensuring Access to Medicaid Services
”

In May 2024, CMS finalized a rule intended to improve access to services and quality of care for Medicaid beneficiaries across fee-for-service and managed care delivery systems. The final rule includes significant provisions related to HCBS, including the “80/20” or “payment adequacy” requirement, which will require states to ensure by mid-2030 that at least 80% of all Medicaid payments a provider receives for homemaker, home health aide, and personal care services, less certain excluded costs, under specified programs are spent on total compensation (including benefits) for direct care workers furnishing these services, rather than administrative overhead or profit, subject to limited exceptions. The final rule includes several other measures intended to promote transparency and enhance quality and access to services, including a variety of reporting requirements for states. Given the long implementation period and the likelihood of further changes as a result of litigation, administration and congressional changes, further rule-making and state changes in response to the final rule, it is premature to predict the ultimate impact of the final rule on our business.

       30

Table of Contents

Developments in Public Policy

The outcome of the 2024 federal election increased regulatory uncertainty and the potential for significant policy changes. President Trump has issued executive orders that impact or may impact the healthcare industry, including an order establishing a presidential advisory commission, the Department of Government Efficiency (“DOGE”), focused on restructuring and streamlining government agencies and reducing or eliminating regulations and federal government programs and other expenditures. In March 2025, the Department of Health and Human Services (“HHS”) announced a significant restructuring in accordance with the President’s DOGE Workforce Optimization Initiative. The restructuring will reduce the HHS workforce and consolidate divisions of HHS, including integrating some functions of the Administration for Community Living, which administers programs that support older adults, into other HHS agencies. HHS also announced a change in its policy on public participation in rulemaking that may negatively affect the ability of industry participants to receive advance notice of and offer feedback on some policy changes. In addition, recent actions by the presidential administration have resulted in holds on or cancellations of congressionally authorized spending as well as interruptions in the distribution of governmental funds.

Changes resulting from legislation and administrative actions at the federal and state levels, may impact home care and other healthcare providers. Federal and state actions may impact funding for, or the structure of, the Medicaid program, including through changes to Medicaid waiver programs, and may shape provider reimbursement rates, eligibility and coverage policies, and other aspects of state Medicaid programs. For example, the budget reconciliation legislation enacted on July 4, 2025, commonly known as the “One Big Beautiful Bill Act” (“OBBBA”), includes policy changes that are expected to reduce federal healthcare spending, including through changes to the Medicaid program, if the law is implemented as enacted. The OBBBA requires changes to Medicaid financing mechanisms such as provider taxes and state-directed payment arrangements. These changes may prohibit states from establishing new provider taxes or increasing rates of existing provider taxes, and may limit the structure and applicability of such taxes, with greater restrictions in states that have expanded Medicaid. Some of these changes, which will be phased in over time, are intended to reduce the federal matching funds received by state Medicaid programs. In addition, the OBBBA limits Medicaid eligibility and increases administrative and financial obligations for states and enrollees, although most of these reforms are focused on adults in the Medicaid expansion population. Future Medicaid reform initiatives at the federal and state levels may further reduce Medicaid expenditures and involve additional administrative changes. Reduced funding for Medicaid or other changes to Medicaid programs, including Medicaid waiver programs, could put pressure on state budgets and result in reductions to Medicaid payments, scope of coverage and enrollment. Such reductions could, in turn, affect our reimbursements for services rendered. We expect the impact of the OBBBA on home care businesses, including our business, will be less significant than the impact on other healthcare businesses.

The federal deficit and other federal and state budgetary pressures affect government healthcare program expenditures, and we anticipate that these effects will continue. For example, the OBBBA is expected to decrease federal healthcare spending, particularly with respect to Medicaid, and is generally expected to increase pressures on state budgets, particularly in Medicaid expansion states. The impact on state budgets may result in state-level changes such as reductions to the scope of covered services or tax increases. In addition, the OBBBA increases the federal budget deficit in a manner that triggers a statutorily mandated sequestration under the Pay-As-You-Go Act of 2010. As a result, a Medicare spending reduction of up to 4% is required to take effect in early 2026, absent congressional action. These reductions would be in addition to the payment reductions required by the Budget Control Act of 2011 and subsequent legislation, which are currently set to continue through the first ten months of federal fiscal year 2032. It is possible that future deficit reduction legislation will impose additional spending reductions.

The federal government entered a partial shutdown effective October 1, 2025. Although Medicare and Medicaid reimbursement generally remains available through a shutdown and we are not currently experiencing delays in payment, we may be exposed to indirect effects related to government agencies operating at reduced capacity and lack of congressional action on significant issues.

       31

Table of Contents

Components of our Statements of Income

Net Service Revenues

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment, and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers and payors, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers.

In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.

Cost of Service Revenues

We incur direct care wages, payroll taxes, and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.

General and Administrative Expenses

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors, and office administrative costs. Personnel costs include wages, payroll taxes, and employee benefits. Facility costs include rents, utilities, and postage, telephone, and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing, and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts, and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs, and asset write-offs are also included in general and administrative expenses.

Depreciation and Amortization Expenses

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks, and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.

Interest Expense

Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.

Income Tax Expense

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rates were 
24.7%
 and 26.1% for the three months ended September 30, 2025 and 2024, respectively. The effective income tax rates were 
24.3%
 and 26.1% for the nine months ended September 30, 2025 and 2024, respectively, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense or benefit and the use of federal employment tax credits.

       32

Table of Contents

Results of Operations 
—
 Consolidated

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

The following table sets forth our unaudited condensed consolidated results of operations.

For the Three Months Ended September 30,

2025

2024

Change

% Of

% Of

Net Service

Net Service

Amount

Revenues

Amount

Revenues

Amount

%

(Amounts in Thousands, Except Percentages)

Net service revenues

$

362,301

100.0

%

$

289,787

100.0

%

$

72,514

25.0

%

Cost of service revenues

245,586

67.8

197,583

68.2

48,003

24.3

Gross profit

116,715

32.2

92,204

31.8

24,511

26.6

General and administrative expenses

79,370

21.9

62,805

21.7

16,565

26.4

Depreciation and amortization

4,408

1.2

3,446

1.2

962

27.9

Total operating expenses

83,778

23.1

66,251

22.9

17,527

26.5

Operating income

32,937

9.1

25,953

9.0

6,984

26.9

Interest income

(760

)

(0.2

)

(1,908

)

(0.7

)

1,148

(60.2

)

Interest expense

3,343

0.9

573

0.2

2,770

483.4

Total interest expense, net

2,583

0.7

(1,335

)

(0.5

)

3,918

(293.5

)

Income before income taxes

30,354

8.4

27,288

9.4

3,066

11.2

Income tax expense

7,506

2.1

7,125

2.5

381

5.3

Net income

$

22,848

6.3

%

$

20,163

7.0

%

$

2,685

13.3

%

Net service revenues increased by 
25.0%
 to 
$362.3
 million for the three months ended 
September 30, 2025
 compared to 
$289.8
 million for the three months ended 
September 30, 2024
. Revenue increased by 
$60.3
 million in our personal care segment, by 
$11.6
 million in our hospice segment and by $0.6 million in our home health segment during the three months ended 
September 30, 2025
, compared to the same period in 
2024
. The increase in our personal care segment was primarily due to the completion of the Gentiva Acquisition on December 2, 2024 and the Helping Hands Acquisition on August 1, 2025. The increase in our hospice segment revenue was due to organic growth.

Gross profit, expressed as a percentage of net service revenues, increased to 
32.2%
 for the three months ended 
September 30, 2025
, compared to 
31.8%
 for the same period in 
2024
 due to growth in our higher margin hospice segment and the New York Asset Sale.

General and administrative expenses increased to 
$79.4
 million for the three months ended 
September 30, 2025
, as compared to 
$62.8
 million for the three months ended 
September 30, 2024
. The increase in general and administrative expenses was primarily due to a non-recurring $1.5 million recruitment expense as well as the Gentiva and Helping Hands Acquisitions that resulted in an increase in administrative employee wage, bonus, tax, and benefit costs of $10.3 million. General and administrative expenses, expressed as a percentage of net service revenues, marginally increased to 
21.9%
 for the three months ended 
September 30, 2025
, from 21.7% for the three months ended 
September 30, 2024
.

Interest expense increased to 
$3.3
 million for the three months ended 
September 30, 2025
 from 
$0.6
 million for the three months ended 
September 30, 2024
. The increase in interest expense was primarily due to higher average outstanding borrowings held under our credit facility for the three months ended 
September 30, 2025
,compared to the three months ended 
September 30, 2024
.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 24.7% and 26.1% for the three months ended 
September 30, 2025 and 2024
, respectively. Our lower effective income tax rate for the three months ended 
September 30, 2025
, was principally due to a higher excess tax benefit with a higher benefit from the use of federal employment tax credits. For the three months ended 
September 30, 2025 and 2024
, the excess tax benefit and federal employment tax credits were 6.5% and 3.1%, respectively.

       33

Table of Contents

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

The following table sets forth our unaudited condensed consolidated results of operations.

For the Nine Months Ended September 30,

2025

2024

Change

% Of

% Of

Net Service

Net Service

Amount

Revenues

Amount

Revenues

Amount

%

(Amounts in Thousands, Except Percentages)

Net service revenues

$

1,049,452

100.0

%

$

857,455

100.0

%

$

191,997

22.4

%

Cost of service revenues

711,183

67.8

583,916

68.1

127,267

21.8

Gross profit

338,269

32.2

273,539

31.9

64,730

23.7

General and administrative expenses

229,667

21.9

187,444

21.9

42,223

22.5

Depreciation and amortization

12,264

1.2

10,316

1.2

1,948

18.9

Total operating expenses

241,931

23.1

197,760

23.1

44,171

22.3

Operating income

96,338

9.2

75,779

8.8

20,559

27.1

Interest income

(1,845

)

(0.2

)

(2,805

)

(0.3

)

960

(34.2

)

Interest expense

10,886

1.0

5,445

0.6

5,441

99.9

Total interest expense, net

9,041

0.9

2,640

0.3

6,401

242.5

Income before income taxes

87,297

8.3

73,139

8.5

14,158

19.4

Income tax expense

21,169

2.0

19,067

2.2

2,102

11.0

Net income

$

66,128

6.3

%

$

54,072

6.3

%

$

12,056

22.3

%

Net service revenues increased by 
22.4%
 to 
$1,049.5
 million for the 
nine months ended September 30, 2025
 compared to 
$857.5
 million for the 
nine months ended September 30, 2024
. Revenue increased by 
$167.0
 million in our personal care segment, by 
$23.3
 million in our hospice segment and by 
$1.7
 million in our home health segment during the 
nine months ended September 30, 2025
, compared to the same period in 
2024
. The increase in our personal care and home health segments was primarily due to the completion of the Gentiva Acquisition on December 2, 2024. The increase in our hospice segment revenue was due to organic growth.

Gross profit, expressed as a percentage of net service revenues, increased to 
32.2%
 for the 
nine months ended September 30, 2025
, compared to 
31.9%
 for the same period in 
2024
 due to growth in our higher margin hospice segment and the New York Asset Sale.

General and administrative expenses increased to 
$229.7
 million for the 
nine months ended September 30, 2025
, compared to 
$187.4
 million for the 
nine months ended September 30, 2024
. The increase in general and administrative expenses was primarily due to a $1.5 million non-recurring recruitment expense as well as the Gentiva and Helping Hands Acquisitions that resulted in an increase in administrative employee wage, bonus, tax, and benefit costs of $29.8 million. General and administrative expenses, expressed as a percentage of net service revenues, was consistent at 
21.9%
 for both the 
nine months ended September 30, 2025
 and the 
nine months ended September 30, 2024
.

Interest expense increased to 
$10.9
 million for the 
nine months ended September 30, 2025
 from 
$5.4
 million for the 
nine months ended September 30, 2024
. The increase in interest expense was primarily due to higher average outstanding borrowings held under our credit facility for the 
nine months ended September 30, 2025
, compared to
 the nine months ended September 30, 2024
.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 24.3% and 26.1% for the 
nine months ended September 30, 2025 and 2024
, respectively. Our lower effective income tax rate for the 
nine months ended September 30, 2025
, was principally due to a higher excess tax benefit with a lower benefit from the use of federal employment tax credits. For the 
nine months ended September 30, 2025 and 2024
, the excess tax benefit and federal employment tax credits were 5.4% and 3.1%, respectively.

       34

Table of Contents

Results of Operations 
–
 Segments

The following tables and related analysis summarize our operating results and business metrics by segment:

Personal Care Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

Change

2025

2024

Change

% of

% of

% of

% of

Segment

Segment

Segment

Segment

Net Service

Net Service

Net Service

Net Service

Amount

Revenues

Amount

Revenues

Amount

%

Amount

Revenues

Amount

Revenues

Amount

%

(Amounts in Thousands, Except Percentages)

(Amounts in Thousands, Except Percentages)

Operating Results

Net service revenues

$

275,770

100.0

%

$

215,433

100.0

%

$

60,337

28.0

%

$

803,238

100.0

%

$

636,253

100.0

%

$

166,985

26.2

%

Cost of services revenues

200,108

72.6

156,273

72.5

43,835

28.1

580,452

72.3

461,564

72.5

118,888

25.8

Gross profit

75,662

27.4

59,160

27.5

16,502

27.9

222,786

27.7

174,689

27.5

48,097

27.5

General and administrative expenses

24,572

8.9

17,489

8.1

7,083

40.5

72,466

9.0

49,907

7.8

22,559

45.2

Segment operating income

$

51,090

18.5

%

$

41,671

19.4

%

$

9,419

22.6

%

$

150,320

18.7

%

$

124,782

19.7

%

$

25,538

20.5

%

Business Metrics (Actual Numbers, Except Billable Hours in Thousands)

Locations at period end

202

153

Average billable census * 
(1)

50,480

37,701

12,779

33.9

%

50,708

37,803

12,905

34.1

%

Billable hours * 
(2)

10,855

7,776

3,079

39.6

31,615

23,098

8,517

36.9

Average billable hours per census per month * 
(2)

72.0

68.7

3.3

4.8

70.2

67.8

2.4

3.5

Billable hours per business day * 
(2)

164,474

117,822

46,652

39.6

162,128

117,849

44,279

37.6

Revenues per billable hour * 
(2)

$

25.40

$

27.66

$

(2.26

)

(8.2

)%

$

25.40

$

27.49

$

(2.09

)

(7.6

)%

Same store growth revenue % *
 (3)

6.6

%

6.8

%

(0.2

)

(2.9

)

7.1

%

8.4

%

(1.3

)

(15.5

)

(1)

Average billable census is the number of unique clients receiving a billable service during the year and is the total census divided by months in operation during the period. Average billable census did not include New York operations for the three and nine months ended September 30, 2025, and included 1,133 and 1,285 for the three and nine months ended September 30, 2024, respectively (See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, 
Divesture).

(2)

Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue, attributed to billable bonus hours, divided by billable hours.

       35

Table of Contents

(3)

Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures and ARPA associated revenue from this calculation.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 32.0% and 38.6% of our net service revenues for the three months ended September 30, 2025 and 2024, respectively, and accounted for 32.6%

and 38.5% of our net service revenues for the nine months ended September 30, 2025 and 2024, respectively. One payor, the Illinois Department on Aging, accounted for 
18.1%
 and 21.4% of net service revenues for the three months ended September 30, 2025 and 2024, respectively, and accounted for 
18.4%
 and 21.1% of net service revenues for the nine months ended September 30, 2025 and 2024, respectively.

Net service revenues from state, local, and other governmental programs accounted for 50.5% and 54.2% of net service revenues for the three months ended September 30, 2025 and 2024, respectively. Managed care organizations accounted for 46.2% and 43.3% of net service revenues for the three months ended September 30, 2025 and 2024, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues. Net service revenues from state, local, and other governmental programs accounted for 51.1% and 53.0% of net service revenues for the nine months ended September 30, 2025 and 2024, respectively. Managed care organizations accounted for 45.6%

and 44.3% of net service revenues for the nine months ended September 30, 2025 and 2024, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues.

Net service revenues increased by 28.0% for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. Net service revenues included a 8.2%
 decrease in revenues per billable hour
 for the three months ended September 30, 2025, 
due to lower reimbursement rates attributable to the Gentiva and Helping Hands Acquisitions, as well as the New York Asset Sale, 
compared to the three months ended September 30, 2024.

Gross profit, expressed as a percentage of net service revenues, 
increased to 
27.7% for the nine months ended September 30, 2025 from 27.5% for the nine months ended September 30, 2024. 
This increase was due to decreases in direct payroll and benefits expenses as a percentage of revenue for the 
nine months ended September 30, 2025
 primarily related to the New York Asset Sale.

The personal care segment’s general and administrative expenses primarily consist of administrative employee wages, taxes, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 9.0% and 7.8% for the nine months ended September 30, 2025 and 2024, respectively.

       36

Table of Contents

Hospice Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

Change

2025

2024

Change

% of

% of

% of

% of

Segment

Segment

Segment

Segment

Net Service

Net Service

Net Service

Net Service

Amount

Revenues

Amount

Revenues

Amount

%

Amount

Revenues

Amount

Revenues

Amount

%

(Amounts in Thousands, Except Percentages)

(Amounts in Thousands, Except Percentages)

Operating Results

Net service revenues

$

68,891

100.0

%

$

57,309

100.0

%

$

11,582

20.2

%

$

192,540

100.0

%

$

169,202

100.0

%

$

23,338

13.8

%

Cost of services revenues

34,865

50.6

30,469

53.2

4,396

14.4

99,549

51.7

89,166

52.7

10,383

11.6

Gross profit

34,026

49.4

26,840

46.8

7,186

26.8

92,991

48.3

80,036

47.3

12,955

16.2

General and administrative expenses

15,211

22.1

14,070

24.6

1,141

8.1

44,737

23.2

40,975

24.2

3,762

9.2

Segment operating income

$

18,815

27.3

%

$

12,770

22.3

%

$

6,045

47.3

%

$

48,254

25.1

%

$

39,061

23.1

%

$

9,193

23.5

%

Business Metrics (Actual Numbers)

Locations at period end

39

38

Admissions *
 (1)

3,326

3,105

221

7.1

%

10,060

9,771

289

3.0

%

Average daily census * 
(2)

3,889

3,534

355

10.0

3,720

3,457

263

7.6

Average discharge length of stay *
 (3)

89.6

96.3

(6.8

)

(7.0

)

92.6

92.8

(0.2

)

(0.2

)

Patient days * 
(4)

357,221

325,160

32,061

9.9

1,012,045

947,241

64,804

6.8

Revenue per patient day *
 (5)

$

191.66

$

176.25

$

15.41

8.7

$

190.21

$

179.43

$

10.78

6.0

Organic growth

- Revenue *
 (6)

19.0

%

3.5

%

15.5

442.9

13.0

%

5.2

%

7.8

150.0

- Average daily census * 
(6)

9.5

%

2.1

%

7.4

352.4

%

7.1

%

0.8

%

6.3

787.5

%

(1)

Represents referral process and new patients on service during the period.

(2)

Average daily census is total patient days divided by the number of days in the period.

(3)

Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period.

(4)

Patient days is days of service for all patients in the period.

(5)

Revenue per patient day is hospice revenue divided by the number of patient days in the period.

(6)

Revenue organic growth and average daily census organic growth reflect the change in year-over-year revenue and average daily census for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the

performance of existing stores, while excluding the impact of acquisitions, new store openings and closures.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

       37

Table of Contents

The hospice segment generates revenue by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care.

Net service revenues from Medicare accounted for 93.1% and 91.5% for the three months ended September 30, 2025 and 2024, respectively, and 92.9% and 91.1% for the nine months ended September 30, 2025 and 2024, respectively. Net service revenues from managed care organizations accounted for 3.2% for both the three months ended September 30, 2025 and 2024, and 3.2% and 3.3% for the nine months ended September 30, 2025 and 2024, respectively.

Net service revenues increased by $11.6
 million
 and $23.3 million for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024, primarily attributed to organic growth in average daily census.

Gross profit, expressed as a percentage of net service revenues, was 49.4% and 46.8% for the three months ended September 30, 2025 and 2024, respectively, and 48.3% and 47.3% for the nine months ended September 30, 2025 and 2024, respectively. For the three and nine months ended September 30, 2025, the increase was mainly attributed to organic growth.

The hospice segment’s general and administrative expenses primarily consist of administrative employee wage, tax, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 22.1% and 24.6% for the three months ended September 30, 2025 and 2024, respectively, and 23.2% and 24.2% for the nine months ended September 30, 2025 and 2024, respectively. 

Home Health Segment

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2025

2024

Change

2025

2024

Change

% of

% of

% of

% of

Segment

Segment

Segment

Segment

Net Service

Net Service

Net Service

Net Service

Amount

Revenues

Amount

Revenues

Amount

%

Amount

Revenues

Amount

Revenues

Amount

%

(Amounts in Thousands, Except Percentages)

(Amounts in Thousands, Except Percentages)

Operating Results

Net service revenues

$

17,640

100.0

%

$

17,045

100.0

%

$

595

3.5

%

$

53,674

100.0

%

$

52,000

100.0

%

$

1,674

3.2

%

Cost of services revenues

10,613

60.2

10,841

63.6

(228

)

(2.1

)

31,182

58.1

33,186

63.8

(2,004

)

(6.0

)

Gross profit

7,027

39.8

6,204

36.4

823

13.3

22,492

41.9

18,814

36.2

3,678

19.5

General and administrative expenses

4,480

25.4

4,338

25.5

142

3.3

12,549

23.4

13,447

25.9

(898

)

(6.7

)

Segment operating income

$

2,547

14.4

%

$

1,866

10.9

%

$

681

36.5

%

$

9,943

18.5

%

$

5,367

10.3

%

$

4,576

85.3

%

Business Metrics (Actual Numbers)

Locations at period end

24

23

New admissions *
 (1)

4,577

4,437

140

3.2

%

13,853

14,257

(404

)

(2.8

)%

Recertifications * 
(2)

2,627

3,353

(726

)

(21.7

)

8,442

9,798

(1,356

)

(13.8

)

Total volume *
 (3)

7,204

7,790

(586.0

)

(7.5

)

22,295

24,055

(1,760.0

)

(7.3

)

Visits * 
(4)

90,639

104,730

(14,091

)

(13.5

)

279,924

322,713

(42,789

)

(13.3

)

Organic growth

- Revenue * 
(5)

(2.8

)%

(1.7

)%

(1.1

)

64.7

(2.3

)%

(5.4

)%

3.1

(57.4

)

- Admissions * 
(5)

(0.1

)%

(5.7

)%

5.6

(98.2

)%

(3.9

)%

(0.3

)%

(3.6

)

1200.0

%

(1)

Represents new patients during the period.

       38

Table of Contents

(2)

A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period.

(3)

Total volume is total admissions and total recertifications in the period.

(4)

Represents number of services to patients in the period.

(5)

Revenue organic growth and admissions organic growth reflect the change in year-over-year revenue and admissions for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the

performance of existing stores, while excluding the impact of acquisitions, new store openings, and closures.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 65.9% and 70.6%, managed care organizations accounted for 25.5% and 24.7%, and state, local, and other governmental programs accounted for 5.6% and 0.0% for the three months ended September 30, 2025 and 2024, respectively. Net service revenues from Medicare accounted for 68.4% and 69.6%, managed care organizations accounted for 23.4% and 25.6%, and state, local, and other governmental programs accounted for 5.3% and 0.0% for the nine months ended September 30, 2025 and 2024, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.

Net service revenues remained constant for the three months ended September 30, 2025, compared to the three months ended September 30, 2024, and increased by $1.7
 million
 for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024, 
primarily due to the Gentiva Acquisition.

Gross profit, expressed as a percentage of net service revenues, was 39.8% and 36.4% for the three months ended September 30, 2025 and 2024, respectively, and 41.9% and 36.2% for the nine months ended September 30, 2025 and 2024, respectively. For the three and nine months ended September 30, 2025, 
the increase was mainly attributed to a decrease in direct care wages, taxes and benefit costs as a percentage of net service revenues, compared to the 
three and nine months ended September 30, 2024
.

The home health segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 25.4% and 25.5% for the three months ended September 30, 2025 and 2024, respectively, and 23.4% and 25.9% for the nine months ended September 30, 2025 and 2024, respectively. 

       39

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At September 30, 2025 and December 31, 2024, we had cash balances of $101.9 million and $98.9 million, respectively. At September 30, 2025, we had a 
$650.0
 million revolving credit facility and a $150.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility was extended to July 30, 2028.

During the nine months ended September 30, 2025, we used $3.4 million in cash to fund the Jacksonville Acquisition and the Great Lakes Acquisition, drew $11.3 million on the revolver portion of our credit facility to fund, in part, the purchase price paid in connection with the Helping Hands Acquisition, and repaid $80.0 million under our revolving credit facility. As of September 30, 2025, we had a total of $154.3 million in revolving loans, with an interest rate of 
5.92%
 outstanding on our credit facility and after giving effect to the amount drawn on our credit facility, approximately 
$7.9
 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had $650.0 million of capacity and $487.7 million available for borrowing under our credit facility. At December 31, 2024, we had a total of $223.0 million revolving credit loans, with an interest rate of 6.34%, outstanding on our credit facility.

Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At September 30, 2025, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

See Note 9 to the Notes to Unaudited Condensed Consolidated Financial Statements, 
Long-Term Debt
, for additional details of our long-term debt.

Current Macroeconomic Conditions and American Rescue Plan Act of 2021 Relief Funding

Economic conditions in the United States continue to be challenging in various respects. For example, the United States economy continues to experience inflationary pressures, elevated interest rates, challenging labor market conditions and uncertainty regarding the impact of increased tariffs and trade disruptions. Any economic downturn would pose a risk to states’ revenues, which in turn could affect our reimbursements and collections received for services rendered. Depending on the severity and length of any potential economic downturn as well as the extent of any federal support, states could face significant fiscal challenges and revise their revenue forecasts and adjust their budgets, and sales tax collections and income tax withholdings could be depressed.

       40

Table of Contents

ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the ARPA provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through March 31, 2025, but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-2026. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three and nine months ended September 30, 2025, the Company did not receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through September 30, 2025, the Company utilized $2.2 million and $5.5 million during the three and nine months ended September 30, 2025, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of September 30, 2025, the deferred portion of ARPA funding of $5.8 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

The following table summarizes changes in our cash flows:

For the Nine Months Ended September 30,

2025

2024

(Amounts in Thousands)

Net cash provided by operating activities

$

92,744

$

106,016

Net cash used in investing activities

(22,444

)

(124

)

Net cash (used in) provided by financing activities

(67,293

)

52,169

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest, and taxes. Net cash provided by operating activities was $92.7 million for the nine months ended September 30, 2025, compared to net cash provided by operating activities of $106.0 million for the same period in 2024. 
The decrease in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of receipt and utilization of government stimulus funds. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the 
nine months ended September 30, 2025
 as compared to the 
nine months ended September 30, 2024
. The related receivables due from the Illinois Department on Aging represented 16.6% and 21.7% of the Company’s net accounts receivable at 
September 30, 2025
 and 
September 30, 2024
, respectively.

Net cash used in investing activities for the nine months ended September 30, 2025, primarily consisted of $24.2 million of net cash used for the Helping Hands Acquisition, the Jacksonville Acquisition and the Great Lakes Acquisition, $5.1 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets, offset by $3.8 million in proceeds received relating to the New York Asset Sale and $2.9 million in proceeds received relating to the Gentiva Acquisition. Net cash used in investing activities for the nine months ended September 30, 2024 primarily consisted of $0.4 million of net cash used for the Upstate acquisition and $4.4 million of cash used for property and equipment purchases, offset by $4.6 million in proceeds received relating to the New York Asset Sale.

       41

Table of Contents

Net cash used in financing activities for the nine months ended September 30, 2025, primarily consisted of an
 $80.0 
million payment on our revolving credit facility, offset by borrowings of $11.3 million on the revolver portion of our credit facility to fund, in part, the Helping Hands Acquisition and cash received from the exercise of stock options of
 $1.5 
million. Net cash provided by financing activities for the nine months ended September 30, 2024 primarily consisted of $126.4 million payment on our revolving credit facility, offset by $175.6 million in net proceeds received from the Public Offering, and also included cash received from the exercise of stock options of $3.0 million.

Outstanding Accounts Receivable

Gross accounts receivable as of September 30, 2025 and December 31, 2024 were approximately 
$136.9 million
 and $126.4 million, respectively. Outstanding accounts receivable, net of allowance for credit losses, 
increased by $11.2 million
 as of September 30, 2025 as compared to December 31, 2024. Accounts receivable for the Illinois Department on Aging decreased approximately
 $3.6
 million during the nine months ended September 30, 2025. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 
35 days 
and 39 days at September 30, 2025 and December 31, 2024, respectively. The DSOs for our largest payor, the Illinois Department on Aging, were 
33 days
 and 40 days at September 30, 2025 and December 31, 2024, respectively.

Off-Balance Sheet Arrangements

As of September 30, 2025, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

Critical Accounting Policies and Estimates

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2024, filed on February 25, 2025.

Recently Issued Accounting Pronouncements

Refer to Note 2 to the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.

       42

Table of Contents

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of September 30, 2025, we had outstanding borrowings of approximately $154.3 
million
 on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the nine month period ended September 30, 2025, our net income would have decreased by 
$1.1 million, or $0.06
 per diluted share. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

       43

Table of Contents

PART II 
–
 OTHER INFORMATION

Item 1.

Legal Proceedings

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

Item 1A.      Risk Factors

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2024, filed on February 25, 2025. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

       44

Item 
5.

Other Information

During the quarter ended 
 September 30, 2025
, each of the following directors and Section 
16
 officers terminated a 
Rule

10b5
-
1
 Trading Arrangement (as defined in Item 
408
(a) of Regulation S-K) to sell common shares:

Shares Vesting and Subject to

Other Shares Being Sold

Name

Title

Adoption Date

Expiration Date (
1
)

Termination
 Date

Sell-To-Cover (
2
)

(Subject to Certain Conditions)

W. Bradley Bickham

President and Chief Operating Officer

 March 5, 2025

February 24, 2026

August 13, 2025

12,173

n/a

(
1
) Each plan would have expired on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement.

(
2
) This column indicates the total number of shares vesting in connection with equity awards, 
not
 the number of shares to be sold. The actual number of shares to be sold would have been a smaller number based on whatever was required to satisfy payment of applicable withholding taxes under sell-to-cover arrangements.

During the quarter ended 
 September 30, 2025
, each of the following directors and Section 
16
 officers adopted a Rule 
10b5
-
1
 Trading Arrangement (as defined in Item 
408
(a) of Regulation S-K) to sell common shares:

Shares Vesting and Subject to

Other Shares Being Sold

Name

Title

Adoption
 Date

Expiration Date (
1
)

Sell-To-Cover (
2
)

(Subject to Certain Conditions)

W. Bradley Bickham

President and Chief Operating Officer

August 13, 2025

March 10, 2026

26,760

n/a

W. Bradley Bickham

President and Chief Operating Officer

September 5, 2025

March 26, 2026

36,161

n/a

(
1
) Each plan will expire on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement.

(
2
) This column indicates the total number of shares vesting in connection with equity awards, 
not
 the number of shares to be sold. The actual number of shares to be sold will be a smaller number based on whatever is required to satisfy payment of applicable withholding taxes under sell-to-cover arrangements.

       45

Table of Contents

Item 6.

Exhibits 

EXHIBIT INDEX

Incorporated by Reference

Exhibit

Number

Description of Document

Form

File No.

Date Filing

Exhibit

Number

3.1

Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.

10-Q

001-34504

11/20/2009

3.1

3.2

Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.

10-Q

001-34504

05/09/2013

3.2

4.1

Form of Common Stock Certificate.

S-1

333-160634

10/02/2009

4.1

10.1

Employment and Non-Competition Agreement, dated August 4, 2025, by and between Addus Healthcare, Inc. and Heather Dixon.

8-K

001-34504

08/07/2025

10.1

10.2

Amended and Restated Retention and Transition Agreement, dated August 4, 2025, by and between Addus Healthcare, Inc. and W. Bradley Bickham.

8-K

001-34504

08/07/2025

10.2

31.1

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Calculation Linkbase Document.

101.LAB

Inline XBRL Taxonomy Label Linkbase Document.

101.PRE

Inline XBRL Presentation Linkbase Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

       46

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ADDUS HOMECARE CORPORATION

Date: November 4, 2025

By:

/s/ R. DIRK ALLISON

R. Dirk Allison

Chairman and Chief Executive Officer

(As Principal Executive Officer)

Date: November 4, 2025

By:

/s/ BRIAN POFF

Brian Poff

Chief Financial Officer

(As Principal Financial Officer)

       47